Mette Schmedes

Mrs. Mette Schmedes

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMette Schmedes
Mette Schmedes
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
EAEli Kristin Aadland
Eli Kristin Aadland
HJHélène Jacques
Hélène Jacques
CLCharles Lavigne
Charles Lavigne
Hanne Christine BertramHanne Christine Bertram
Hanne Christine Bertram
The metabolic effects associated with intake of different dietary protein sources are not well characterized. We aimed to elucidate how two diets that varied in main protein sources affected the fasting and postprandial serum metabolites and lipid species. In a randomized controlled trial with crossover design, healthy adults (n = 20) underwent a 4-week intervention with two balanced diets that varied mainly in protein source (lean-seafood versus non-seafood proteins). Nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry analyses were applied to examine the effects of the two diets on serum metabolites. In the fasting state, the lean-seafood diet period, as opposed to the non-seafood diet period, significantly decreased the serum levels of isoleucine and valine, and during the postprandial state, a decreased level of lactate and increased levels of citrate and trimethylamine N-oxide were observed. The non-seafood diet significantly increased the fasting level of 26 lipid species including ceramides 18:1/14:0 and 18:1/23:0 and lysophosphatidylcholines 20:4 and 22:5, as compared to the lean-seafood diet. Thus, the lean-seafood diet decreased circulating isoleucine and valine levels, whereas the non-seafood diet elevated the levels of certain ceramides, metabolites that are associated with insulin-resistance.

19 October 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PSPedram Shokouh
Pedram Shokouh
PJPer Bendix Jeppesen
Per Bendix Jeppesen
KHKjeld Hermansen
Kjeld Hermansen
CLChristoffer Laustsen
Christoffer Laustsen
HSHans Stødkilde-Jørgensen
Hans Stødkilde-Jørgensen
SGSøren Gregersen
Søren Gregersen
The literature is inconsistent as to how coffee affects metabolic syndrome (MetS), and which bioactive compounds are responsible for its metabolic effects. This study aimed to evaluate the effects of unfiltered coffee on diet-induced MetS and investigate whether or not phenolic acids and trigonelline are the main bioactive compounds in coffee. Twenty-four male Sprague‒Dawley rats were fed a high-fat (35% W/W) diet plus 20% W/W fructose in drinking water for 14 weeks, and were randomized into three groups: control, coffee, or nutraceuticals (5-O-caffeoylquinic acid, caffeic acid, and trigonelline). Coffee or nutraceuticals were provided in drinking water at a dosage equal to 4 cups/day in a human. Compared to the controls, total food intake (p = 0.023) and mean body weight at endpoint (p = 0.016) and estimated average plasma glucose (p = 0.041) were lower only in the coffee group. Surrogate measures of insulin resistance including the overall fasting insulin (p = 0.010), endpoint HOMA-IR (p = 0.022), and oral glucose tolerance (p = 0.029) were improved in the coffee group. Circulating triglyceride levels were lower (p = 0.010), and histopathological and quantitative (p = 0.010) measurements indicated lower grades of liver steatosis compared to controls after long-term coffee consumption. In conclusion, a combination of phenolic acids and trigonelline was not as effective as coffee per se in improving the components of the MetS. This points to the role of other coffee chemicals and a potential synergism between compounds.

26 April 2018 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
PDF file
MSMette Schmedes
Mette Schmedes
LBLine Q Bendtsen
Line Q Bendtsen
SGSisse Gomes
Sisse Gomes
BLBjørn Liaset
Bjørn Liaset
Jens HolstJens Holst
Jens Holst
Hanne Christine BertramHanne Christine Bertram
Hanne Christine Bertram

21 August 2018 in Preprints.org
Verified
Preprint
Open access
PSPedram Shokouh
Pedram Shokouh
PJPer Bendix Jeppesen
Per Bendix Jeppesen
KHKjeld Hermansen
Kjeld Hermansen
CLChristoffer Laustsen
Christoffer Laustsen
HSHans Stødkilde-Jørgensen
Hans Stødkilde-Jørgensen
SGSoeren Gregersen
Soeren Gregersen
Literature is inconsistent as to how coffee affects the features of the metabolic syndrome (MetS), and which bioactive compounds are responsible for its metabolic effects. We aimed to compare the in-vivo effects of unfiltered coffee with a selected mixture of its compounds on diet-induced MetS. 24 male Sprague-Dawley rats were fed a high-fat (35% W/W) food plus 20% W/W fructose in drinking water for 14 weeks, and were randomized into three groups: control, coffee, or nutraceuticals (5-O-caffeoylquinic acid, caffeic acid, and trigonelline). Coffee or nutraceuticals were provided in drinking water in a dosage equal to 4 cups/day in a human. Compared to the controls, only coffee supplementation decreased total food intake, weight gain, and estimated average plasma glucose. Surrogate measures of insulin resistance (fasting insulin, HOMA-IR, and oral glucose tolerance) were improved at endpoint in the coffee group. Circulating triglyceride levels were also reduced by coffee. Histopathological and quantitative measurements indicated lower grades of liver steatosis after long-term coffee consumption. In conclusion, a combination of phenolic acids and trigonelline was not as effective as coffee per se in improving the components of the MetS. This points to the role of other coffee chemicals and a potential synergism between compounds.